secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2023-03-27T23:59:59+00:00
Accession:  0001753926-23-000301
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lipella Pharmaceuticals appoints Daniel Cohen to Board and Audit Committee
--------------------------------------------------------------------------

- Board appointed Daniel Cohen as director on March 21, 2023, expanding board to seven members.
- Cohen will serve until the next annual meeting and then stand for election.
- He was assigned to the Board's audit committee.
- No arrangements or understandings with any other persons regarding his appointment.
- Entered into no transactions requiring disclosure under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623000301/0001753926-23-000301-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623000301/g083458_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-23-000301

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer